ACTRN12609000108213
Not yet recruiting
Phase 2
The utility of 18F-fluro-deoxy-glucose (FDG) and 11C-choline (C) positron emission tomography (PET) scan in men with localised prostate cancer planned for radiotheraupetic management
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Austin Health
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •PSA \> 20 or Gleason score 8\-10 or T stage T3a,T3b or T4
- •Age \> 18 years
- •Eastern Cooperative Oncology Group Performance Status (ECOG) 0 or 1
- •No significant medical or psychiatric illness
- •Written informed consent
- •Be prepared to undergo PET scanning
Exclusion Criteria
- •Any form of prostate malignancy
- •T1\-2c prostate cancer and PSA , 10 and Gleason score \< 7
- •Previous radical prostatectomy
- •Known metastatic prostate cancer
- •Contraindication to MRI
- •Contraindication to androgen ablation
- •Contraindication to PET
- •Commencement of androgen depriavation therapy prior to study entry
- •Previous pelvic radiotherapy
- •Contraindication to radiotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy of [18F]-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography (FDG-PET) in Evaluation of Cytological indeterminate Thyroid nodules prior to Surgery: a multicentre cost-effectiveness study.thyroid lumpthyroid nodule10014713NL-OMON50212Radiologie & Nucleaire Geneeskunde132
Completed
Not Applicable
The usefulness of fluorodeoxyglucose-positron emission tomography as a preoperative diagnostic tool for thymic epithelial tumorsThymic epithelial tumorsJPRN-UMIN000040365Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences51
Not yet recruiting
Phase 3
18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed TomographySolitary Pulmonary NoduleOncology18F-2-fluoro-2-deoxy-D-glucoseAdverse EventNCT04615156Eastern Health, Canada10,000
Recruiting
Not Applicable
Prognostic Siginificance of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Limited Stage Small Cell Lung Cancerimited Stage Small Cell Lung CancerJPRN-UMIN000004385ung Oncology Group in Kyushu, Japan (LOGIK)38
Completed
Not Applicable
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)Locally Advanced Squamous Cell Carcinoma of the Head and Neck RegionNCT01179360University Hospital, Antwerp152